Phospholipidomics by phosphorus nuclear magnetic resonance spectroscopy of tissue extracts

Methodologies for Metabolomics: Experimental Strategies and Techniques

Volumn , Issue , 2010, Pages 377-414

  Lutz, Norbert W ^a   Cozzone, Patrick J ^a  

^a University of Aix Marseille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925639671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511996634.019     Document Type: Chapter

References (69)

1. London, E.; Feigenson, G. W. Phosphorus NMR analysis of phospholipids in detergents, J Lipid Res 1979, 20, 408–412.
2. Tome, M. E.; Lutz, N. W.; Briehl, M. M. Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells, Biochim Biophys Acta 2003, 1642, 149–162.
3. Aoki, J.; Inoue, A.; Okudaira, S. Two pathways for lysophosphatidic acid production, Biochim Biophys Acta 2008, 1781, 513–518.
4. Fuchs, B.; Schiller, J.; Wagner, U.; Hantzschel, H.; Arnold, K. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS, Clin Biochem 2005, 38, 925–933.
5. Merchant, T. E.; Minsky, B. D.; Lauwers, G. V.; Diamantis, P. M.; Haida, T.; Glonek, T. Esophageal cancer phospholipids correlated with histopathologic findings: a 31P NMR study, NMR Biomed 1999, 12, 184–188.
6. Solivera, J.; Cerdan, S.; Pascual, J. M.; Barrios, L.; Roda, J. M. Assessment of 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors, NMR Biomed 2009, 22, 663–674.
7. Beloueche-Babari, M.; Chung, Y. L.; Al-Saffar, N. M.; Falck-Miniotis, M.; Leach, M. O. Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy, Br J Cancer 2010, 102, 1–7.
8. Delikatny, E. J.; Cooper, W. A.; Brammah, S.; Sathasivam, N.; Rideout, D. C. Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria, Cancer Res 2002, 62, 1394–1400.
9. Glunde, K.; Jacobs, M. A.; Bhujwalla, Z. M. Choline metabolism in cancer: implications for diagnosis and therapy, Expert Rev Mol Diagn2006, 6, 821–829.
10. Lutz, N. W.; Cozzone, P. J. Multiparametric optimization of (31) P NMR spectroscopic analysis of phospholipids in crude tissue extracts. 2. Line width and spectral resolution, Anal Chem 2010, 82, 5441–5446.
11. Lutz, N. W.; Cozzone, P. J. Multiparametric optimization of (31) P NMR spectroscopic analysis of phospholipids in crude tissue extracts. 1. Chemical shift and signal separation, Anal Chem 2010, 82, 5433–5440.
12. Peterson, B. L.; Cummings, B. S. A review of chromatographic methods for the assessment of phospholipids in biological samples, Biomed Chromatogr 2006, 20, 227–243.
13. Ibrahim, H.; Caudron, E.; Kasselouri, A.; Prognon, P. Interest of fluorescence derivatization and fluorescence probe assisted post-column detection of phospholipids: a short review, Molecules 2010, 15, 352–373.
14. Deschamps, F. S.; Gaudin, K.; Lesellier, E.; Tchapla, A.; Ferrier, D.; Baillet, A.; Chaminade, R. Response enhancement for the evaporative light scattering detection for the analysis of lipid classes and molecular species, Chromatographia 2001, 54, 607–611.
15. Avanti Polar Lipids –discover the difference….http://www.avantilipids.com.
16. Gómez-Fernández, J. C.; Villalám, J. The use of FT-IR for quantitative studies of the apparent pKa of lipid carboxyl groups and the dehydration degree of the phosphate group of phospholipids, Chem Phys Lipids 1998, 96, 41–52.
17. Cui, Z.; Thomas, M. J. Phospholipid profiling by tandem mass spectrometry, Journal of Chromatography B 2009, 877, 2709–2715.
18. Lutz, N. W. Conference page http://bioactivelipidsconf.wayne.edu/2005-Conference. San Francisco, September 11–14, 2005.
19. Farrar, T. C.; Becker, E. D. Pulse and Fourier Transform NMR: Introduction to Theory and Methods; Academic Press: New York, 1971.
20. Gorenstein, D. G. Phosphorous-31 NMR: Principles and Applications; Academic Press: New York, 1984.
21. Günther, H. NMR Spectroscopy. Basic Principles, Concepts, and Applications in Chemistry, Second Edition; John Wiley & Sons: Chichester, 1995.
22. Sanders, J. K. M.; Hunter, B. K. Modern NMR Spectroscopy; Oxford University Press: Oxford, 1993.
23. Ma, H. P.; Eaton, D. C. Acute regulation of epithelial sodium channel by anionic phospholipids, J Am Soc Nephrol 2005, 16, 3182–3187.
24. Rajala, R. V.; Anderson, R. E. Focus on molecules: phosphatidylinositol-4,5-bisphosphate (PIP2), Exp Eye Res 2010, 91, 324–325.
25. Rohacs, T.; Lopes, C. M.; Jin, T.; Ramdya, P. P.; Molnar, Z.; Logothetis, D. E. Specificity of activation by phosphoinositides determines lipid regulation of Kir channels, Proc Natl Acad Sci U S A 2003, 100, 745–750.
26. Leslie, N. R.; Downes, C. P. PTEN: the down side of PI 3-kinase signalling, Cell Signal 2002, 14, 285–295.
27. Schiller, J.; Arnold, K. Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids –a methodological review, Med Sci Monit 2002, 8, MT205–222.
28. Lopez, O.; de la Maza, A.; Coderch, L.; Lopez-Iglesias, C.; Wehrli, E.; Parra, J. L. Direct formation of mixed micelles in the solubilization of phospholipid liposomes by Triton X-100, FEBS Lett 1998, 426, 314–318.
29. Muller, M.; Schiller, J.; Petkovic, M.; Zschornig, O.; Arnhold, J.; Arnold, K. Analysis of enzymatically generated phosphoinositides by (31)P nuclear magnetic resonance spectroscopy, Anal Biochem 2004, 330, 167–171.
30. Puppato, A.; DuPre, D. B.; Stolowich, N.; Yappert, M. C. Effect of temperature and pH on 31P nuclear magnetic resonances of phospholipids in cholate micelles, Chem Phys Lipids 2007, 150, 176–185.
31. Schiller, J.; Zschornig, O.; Petkovic, M.; Muller, M.; Arnhold, J.; Arnold, K. Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR, J Lipid Res 2001, 42, 1501–1508.
32. Pearce, J. M.; Komoroski, R. A. Resolution of phospholipid molecular species by 31P NMR, Magn Reson Med 1993, 29, 724–731.
33. Fuchs, B.; Schiller, J.; Cross, M. A. Apoptosis-associated changes in the glycerophospholipid composition of hematopoietic progenitor cells monitored by 31P NMR spectroscopy and MALDI-TOF mass spectrometry, Chem Phys Lipids 2007, 150, 229–238.
34. Sullentrop, F.; Moka, D.; Neubauer, S.; Haupt, G.; Engelmann, U.; Hahn, J.; Schicha, H. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma, NMR Biomed 2002, 15, 60–68.
35. Jakop, U.; Fuchs, B.; Suss, R.; Wibbelt, G.; Braun, B.; Muller, K.; Schiller, J. The solubilisation of boar spermmembranes by different detergents –amicroscopic, MALDI-TOFMS, (31) P NMR and PAGE study on membrane lysis, extraction efficiency, lipid and protein composition, Lipids Health Dis 2009, 8, 49.
36. Fuchs, B.; Schiller, J.; Suss, R.; Schurenberg, M.; Suckau, D. A direct and simple method of coupling matrix-assisted laser desorption and ionization timeof-flight mass spectrometry (MALDI-TOF MS) to thin-layer chromatography (TLC) for the analysis of phospholipids from egg yolk, Anal Bioanal Chem 2007, 389, 827–834.
37. Renner, C.; Kessler, B.; Oesterhelt, D. Lipid composition of integral purple membrane by 1H and 31P NMR, J Lipid Res 2005, 46, 1755–1764.
38. Dannenberger, D.; Suss, R.; Teuber, K.; Fuchs, B.; Nuernberg, K.; Schiller, J. The intact muscle lipid composition of bulls: an investigation by MALDI-TOF MS and 31P NMR, Chem Phys Lipids 2010, 163, 157–164.
39. Bauer, A.; Schumann, A.; Gilbert, M.; Wilhelm, C.; Hengstler, J. G.; Schiller, J.; Fuchs, B. Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines, Chem Phys Lipids 2009, 159, 21–29.
40. Branca, M.; Culeddu, N.; Fruianu, M.; Serra, M. V. 31P nuclear magnetic resonance analysis of phospholipids in a ternary homogeneous system, Anal Biochem 1995, 232, 1–6.
41. Metz, K. R.; Dunphy, L. K. Absolute quantitation of tissue phospholipids using 31P NMR spectroscopy, J Lipid Res 1996, 37, 2251–2265.
42. Edzes, H. T.; Teerlink, T.; van der Knaap, M. S.; Valk, J. Analysis of phospholipids in brain tissue by 31P NMRat different compositions of the solvent system chloroform-methanol-water, Magn Reson Med 1992, 26, 46–59.
43. Glonek, T. 31P NMR in the analysis of extracted tissue phospholipids, In Phosphorus-31 NMR Spectral Properties in Compound Characterization and Structural Analysis. Quin, L. D., Verkade, J. G., Eds.; VCH Publishers: New York, 1994, pp 283–294.
44. Estrada, R.; Stolowich, N.; Yappert, M. C. Influence of temperature on 31P NMR chemical shifts of phospholipids and their metabolites I. In chloroformmethanol-water, Anal Biochem 2008, 380, 41–50.
45. Pearce, J. M.; Komoroski, R. A.; Mrak, R. E. Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy, Magn ResonMed 2009, 61, 28–34.
46. Sotirhos, N.; Herslof, B.; Kenne, L. Quantitative analysis of phospholipids by 31P-NMR, J Lipid Res 1986, 27, 386–392.
47. Merchant, T. E.; Kasimos, J. N.; Vroom, T.; de Bree, E.; Iwata, J. L.; de Graaf, P. W.; Glonek, T. Malignant breast tumor phospholipid profiles using 31Pmagnetic resonance, Cancer Lett 2002, 176, 159–167.
48. Meneses, P.; Crane, J. M.; Ennis, W. J. A 31P NMR study of extracted phospholipid composition of human skin: full thickness skin, dermis, epidermis and granulation tissue, Skin Research Technol 1998, 4, 71–78.
49. Meneses, P.; Para, P. F.; Glonek, T. 31P NMR of tissue phospholipids: a comparison of three tissue pre-treatment procedures, J Lipid Res 1989, 30, 458–461.
50. Meneses, P.; Glonek, T. High resolution 31P NMR of extracted phospholipids, J Lipid Res 1988, 29, 679–689.
51. Merchant, T. E.; de Graaf, P. W.; Minsky, B. D.; Obertop, H.; Glonek, T. Esophageal cancer phospholipid characterization by 31P NMR, NMR Biomed 1993, 6, 187–193.
52. Kwee, I.; Nakada, T. Phospholipid profile of the human brain: 31P NMR spectroscopy study, Magn Reson Med 1988, 6, 296–299.
53. Srivastava, N. K.; Pradhan, S.; Gowda, G. A.; Kumar, R. In vitro, highresolution 1H and 31P NMRbased analysis of the lipid components in the tissue, serum, and CSF of the patients with primary brain tumors: one possible diagnostic view, NMR Biomed 2010, 233, 113–122.
54. Culeddu, N.; Bosco, M.; Toffanin, R.; Pollesello, P. 31P NMR analysis of phospholipids in crude extracts from different sources: improved efficiency of the solvent system, Magn Reson Chem 1998, 36, 907–912.
55. Malewicz, B.; Baumann, W. J. Alk-1-enylacyl, alkylacyl, and diacyl subclasses of native ethanolamine and choline glycerophospholipids can be quantified directly by phosphorus-31 NMR in solution, Lipids 1996, 31, 1189–1195.
56. Morgan, W. E.; Van Wazer, J.R. Phosphorus-31 spin-lattice relaxation. I. Aqueous orthophosphoric acid and some related systems, J Am Chem Soc 1975, 97, 6347–6352.
57. Li, Z.; Venable, R. M.; Rogers, L. A.; Murray, D.; Pastor, R. W. Molecular dynamics simulations of PIP2 and PIP3 in lipid bilayers: determination of ring orientation, and the effects of surface roughness on a Poisson-Boltzmann description, Biophys J 2009, 97, 155–163.
58. McCain, D. C. 31P Nuclear spin relaxation, In Phosphorus NMR in Biology; Burt, C. T., Ed.; CRC Press: Boca Raton, 1987, pp 26–61.
59. Tolman, C. J.; Kanodia, S.; Roberts, M. F. 31P and 13C NMR analyses of the energy metabolism of the thermophilic anaerobe Clostridium thermocellum, J Biol Chem 1987, 262, 11088–11096.
60. Burgess, J. Metal Ions in Solution; Halsted Press: London, 1978.
61. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem 1957, 226, 497–509.
62. Bligh, E. G.; Dyer, W. J. A rapid method of total lipid extraction and purification, Can J Biochem Physiol 1959, 37, 911–917.
63. Lutz, N. W.; Tome, M. E.; Aiken, N. R.; Briehl, M. M. Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts, NMR Biomed 2002, 15, 356–366.
64. Material properties, http://www.vp-cientific.com/polypropylene%20properties.htm.
65. Pearce, J. M.; Shifman, M. A.; Pappas, A. A.; Komoroski, R. A. Analysis of phospholipids in human amniotic fluid by 31P NMR, Magn ResonMed 1991, 21, 107–116.
66. Sappey-Marinier, D.; Letoublon, R.; Delmau, J. Phosphorus NMR analysis of human white matter in mixed non-ionic detergent micelles, J Lipid Res 1988, 29, 1237–1243.
67. Kumar, V. V.; Manoharan, P. T.; Raghunathan, P. [31P]-nuclear magnetic resonance spin lattice relaxation in lecithin reverse micelles, J Biosci 1982, 4, 449–454.
68. Jacobson, N. E. NMR Spectroscopy Explained; Wiley: New York, 2007.
69. Savorani, F.; Tomasi, G.; Engelsen, S. B. icoshift: a versatile tool for the rapid alignment of 1D NMR spectra, J Magn Reson 2010, 202, 190–202.